Menu
Search
|

Menu

Close
X

Tonghua Dongbao Pharmaceutical Co Ltd 600867.SS (Shanghai Stock Exchange)

18.51 CNY
-0.44 (-2.32%)
As of Sep 12
Previous Close 18.95
Open 18.95
Volume 28,261,211
3m Avg Volume 21,378,677
Today’s High 19.10
Today’s Low 18.30
52 Week High 20.11
52 Week Low 10.94
Shares Outstanding (mil) 1,711.30
Market Capitalization (mil) 33,028.02
Forward P/E 44.04
Dividend (Yield %) 0.17 ( 0.86 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.67 Mean rating from 18 analysts

KEY STATS

Revenue (mm, CNY)
FY19
1,435
FY18
2,693
FY17
2,545
FY16
2,040
EPS (CNY)
FY19
0.262
FY18
0.409
FY17
0.408
FY16
0.325
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
44.04
32.66
Price to Sales (TTM)
vs sector
14.17
7.91
Price to Book (MRQ)
vs sector
8.10
5.38
Price to Cash Flow (TTM)
vs sector
--
24.36
Total Debt to Equity (MRQ)
vs sector
10.53
14.55
LT Debt to Equity (MRQ)
vs sector
1.48
10.20
Return on Investment (TTM)
vs sector
21.13
14.48
Return on Equity (TTM)
vs sector
22.29
15.78

EXECUTIVE LEADERSHIP

Chunsheng Leng
Chairman of the Board, General Manager, Since 2019
Salary: --
Bonus: --
Junye Wang
Chief Accounting Officer, Secretary of the Board, Director, Since
Salary: --
Bonus: --
Hong Chen
Deputy General Manager, Chief Engineer, Since 2012
Salary: --
Bonus: --
Fengqin Li
Director, Since
Salary: --
Bonus: --
Yaren An
Independent Director, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

Dongbao New Village, Tonghua Cou
TONGHUA   JLN   134123

Phone: +86435.5088025
Site: www.thdb.com

TONGHUA DONGBAO PHARMACEUTICAL CO., LTD. is a China-based company, principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company provides biological products, traditional Chinese medicines and chemical supplements, applied in the treatment of diabetes and cardiovascular and cerebrovascular diseases, among others. The Company's main products portfolio consists of recombinant human insulin bulk drugs and injections, zhennaoning capsules, among others. The Company also provides medical instruments, plastic-steel windows and profiles, and operates property business. The Company distributes its products within domestic markets and to overseas markets.

SPONSORED STORIES